Cyclerion Therapeutics, Inc. (CYCN) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $3.24M | +0.2% |
| 2024 | $3.23M | -57.3% |
| 2023 | $7.57M | -43.4% |
| 2022 | $13.38M | -75.2% |
| 2021 | $53.96M | -0.8% |
| 2020 | $54.40M | -42.7% |
| 2019 | $94.89M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $3.24M | +0.2% |
| 2024 | $3.23M | -57.3% |
| 2023 | $7.57M | -43.4% |
| 2022 | $13.38M | -75.2% |
| 2021 | $53.96M | -0.8% |
| 2020 | $54.40M | -42.7% |
| 2019 | $94.89M | — |